Broad Institute Names First Board of Directors | GenomeWeb

NEW YORK (GenomeWeb News) – The Broad Institute of MIT and Harvard has taken its last step, but a significant one, in its year-long transition to a permanent, independent nonprofit by naming its first board of directors, a 14-member panel that will help shape the scientific direction of the genomic medicine research institute, as well as oversee its finances.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.